chr15-48444619-C-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_000138.5(FBN1):c.5959G>C(p.Gly1987Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
The p.Gly1987Arg variant in FBN1 has been identified in 2 individuals with clinical features of Marfan Syndrome and segregated with 1 family member with dilated aortic root and aneurysm (Comeglio 2001 PMID: 11748851, LMM data). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 179119) and was absent from large population studies. Computational prediction tools and conservation analysis suggest that the p.Gly1987Arg variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Gly1987Arg variant is uncertain. ACMG/AMP Criteria applied: PS4_Supporting, PP3, PM2_Supporting. -
- -
Marfan syndrome Pathogenic:1
This missense variant replaces glycine with arginine at codon 1987 in the calcium-binding EGF-like motif 34 of the FBN1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Although functional studies have not been reported for this variant, it changes a highly conserved glycine residue between Cys2-Cys3 in a cbEGF-like domain and is expected to disrupt FBN1 protein function (PMID: 19802897, 31227806). This variant has been reported in at least two individuals affected with Marfan syndrome (PMID: 11748851, 17657824; communication with an external laboratory, ClinVar SCV000738905.3). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. -
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
The p.G1987R variant (also known as c.5959G>C), located in coding exon 48 of the FBN1 gene, results from a G to C substitution at nucleotide position 5959. The glycine at codon 1987 is replaced by arginine, an amino acid with dissimilar properties, and is located in the cbEGF-like #30 domain. This alteration has been reported in an individual with Marfan syndrome (Comeglio P et al. Hum. Mutat., 2001 Dec;18:546-7). Additionally, based on internal structural assessment, this alteration results in the structural distortion of the cbEGF-like #30 domain. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at